News
MediDocHelper launched to Help Accelerate the Digitalization of Healthcare in an Efficient Way
December 5, 2023: MediDocHelper, an automated medical data processing tool from GenomiCare Biotechnology, has been re-released. The system uses generative AI technology to automate the analysis of medical data, transforming various forms of clinical information into...
GenomiCare Biotechnology was invited to participate in 2023 Zhangjiang Cell and Gene Therapy Industry Innovation and Entrepreneurship Competition, and the roadshow projects shined
On November 12, 2023, "The Third Zhangjiang Cell and Gene Therapy Industry Innovation and Entrepreneurship Competition 2023" was successfully held at Zhangjiang Science Hall under the guidance of Science and Technology and Economy Commission of Shanghai Pudong New...
GenomiCare Biotechnology Attends Roche Diagnostics Seminar to Discuss Innovative Collaborations in Integrated Diagnostics and Treatment
On July 27th 2023, the "Roche Diagnostics Integrated Innovation Seminar” hosted by Roche Diagnostics—the global leader in in-vitro diagnosis—concluded successfully in Shanghai. The conference focused on the topic of "patient-centered, precision diagnosis driving...
GenomiCare Biotechnology joins the Roche Accelerator
Shanghai,June 8th, 2022 - GenomiCare Biotechnology (Shanghai) Co., Ltd. (hereinafter referred to as GenomiCare Biotechnology) announces acceptance by the Roche Accelerator. With the support from Roche Accelerator, GenomiCare Biotechnology will further devote...
Highlights from ISPOR (Real World China)
GenomiCare’s sponsored ISPOR Webinar featured a cast of experts from Novartis, Roche, and AstraZeneca in a engaging discussion about Real World Evidence in China. Key takeaways included: On the data, itself: Representativeness and Quality of data is paramount Overall...
ISPOR Webinar- China RWE/RWD
On June 29th, GenomiCare Biotechnology hosted an ISPOR webinar about the opportunities/challenges of RWE/RWD collection from China.
GenomiCare Is on List of 2020 Deloitte China Technology Fast 50 & China Rising Star
The 2020 China Technology Fast 50 & China Rising Star lists were officially published by the Beijing office of Deloitte on December 9 and reported by dozens of news outlets. GenomiCare is on list of the 2020 China Rising Star thanks to its “two-wheel-drive” business model, powerful translational cancer research, and flexible data solutions for clinical oncology drug development.
GenomiCare Wins Two Awards at 2020 International Sci-Tech Innovation Festival
GenomiCare is proud to announce that it has won the 2020 Leading Sci-Tech Innovation Company Award for its innovations in the R&D of cancer precision medicine, and that Dr. Xu Qiang, the company’s founder and CEO, has been named a 2020 Sci-Tech Innovation Leader.
GenomiCare Partners with AWS on HIPAA Eligible Services for Higher Data Security
GenomiCare, Inc. has recently reached a cooperation agreement with AWS on HIPAA compliance. This enables GenomiCare to store, process and utilize masked clinical data in a safer environment and therefore ensures the security and availability of personal health information (PHI) for our clients all over the world.
GenomiCare unveiled the results of PD-L1 immunohistochemistry images in outcome prediction at ASCO 2020
Recently, the summary of the results of GenomiCare PD-L1 immunohistochemistry (IHC) images in outcome prediction was included in the ASCO 2020 (56th Annual Meeting of the American Society of Clinical Oncology), entitled “Application of Automated Segmentation and Classification of PD-L1 Immunohistochemistry Images in Cancer Treatment Prediction”.